3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
2
Myeloid
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Myelodysplastic Syndromes
159
Leukemia, Myeloid, Acute
141
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
67
Myeloproliferative Disorders
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
52
Primary Myelofibrosis
47
Leukemia, Myelomonocytic, Chronic
40
Lymphoma, Non-Hodgkin
36
Leukemia
26
Polycythemia Vera
23
Hodgkin Disease
23
Myelodysplastic-Myeloproliferative Diseases
21
Multiple Myeloma
20
Thrombocythemia, Essential
19
Hematologic Neoplasms
19
Leukemia, Lymphocytic, Chronic, B-Cell
18
Neoplasms
17
Leukemia, Biphenotypic, Acute
15
Anemia, Refractory, with Excess of Blasts
14
Sarcoma
13
Histiocytosis, Langerhans-Cell
13
Glioma
13
Neuroblastoma
12
Hematologic Diseases
12
Wilms Tumor
11
Rhabdoid Tumor
11
Recurrence
11
Osteosarcoma
11
Neuroectodermal Tumors, Primitive, Peripheral
11
Medulloblastoma
11
Interventions
N(4)-oleylcytosine arabinoside
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemorrhage
×
Myeloid
×
90 days
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled